Medicine
Furosemide 20 mg/2 mL injection
Furosemide 20 mg/2 mL injection is a generic prescription medicine for intravenous use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15˚ to 30˚C (59˚…
Key facts
- Active ingredient (INN)
- Furosemide
- Brand
- Sold under the generic name
- Strength
- 20 mg/2 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 25 vials of 2 mL, 5 vials of 2 mL, 1 vial of 2 mL and 9 more
- Manufacturers
- Lifestar PharmaIndiaAvet PharmaceuticalsIndiaCamber PharmaceuticalsIndiaMaiva PharmaIndiaBaxter HealthcareMedical Purchasing SolutionsNorthStar RxDevatis
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15˚ to 30˚C (59˚ to 86˚F) Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03CA01 Furosemide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 February 2014
- Identifiers
- RxCUI 1719290, 1719286, 1719291DailyMed set ID 6a2235e8-d488-2d43-e053-2991aa0aa485, 1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec, f6221cce-e586-4002-bd14-6ec22eb14e2e +6NDC 71872-7059, 23155-473, 31722-309 +7Application ANDA202747, ANDA203428, ANDA217557 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 2 mL in 1 vial | 23155-473-41 | Avet PharmaceuticalsIndia | 2 September 2014 |
| 25 vial, glass in 1 box / 2 mL in 1 vial, glass | 31722-309-32 | Camber PharmaceuticalsIndia | 13 December 2024 |
| 5 vial in 1 carton / 2 mL in 1 vial | 70756-618-05 | Lifestar PharmaIndia | 17 December 2022 |
| 25 vial in 1 carton / 2 mL in 1 vial | 70756-618-25 | Lifestar PharmaIndia | 17 December 2022 |
| 25 vial in 1 carton / 2 mL in 1 vial | 73542-101-25 | Maiva PharmaIndia | 16 June 2025 |
| 5 vial, single-dose in 1 box / 2 mL in 1 vial, single-dose | 36000-063-05 | Baxter Healthcare | 6 February 2014 |
| 25 vial, single-dose in 1 box / 2 mL in 1 vial, single-dose | 36000-282-25 | Baxter Healthcare | 6 February 2014 |
| 25 vial, glass in 1 box / 2 mL in 1 vial, glass | 73043-022-01 | Devatis | 10 August 2024 |
| 1 vial, glass in 1 bag / 2 mL in 1 vial, glass | 71872-7059-1 | Medical Purchasing Solutions | 2 March 2018 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7295-1 | Medical Purchasing Solutions | 25 July 2022 |
| 25 vial in 1 carton / 2 mL in 1 vial | 72603-133-25 | NorthStar Rx | 1 February 2023 |
| 25 vial in 1 carton / 2 mL in 1 vial | 72603-133-25 | NorthStar Rx | 15 July 2025 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 16729-500-08 | — | 5 May 2021 |
| 25 vial in 1 carton / 2 mL in 1 vial | 55150-322-25 | — | 3 May 2019 |
| 5 vial, glass in 1 box / 2 mL in 1 vial, glass | 68083-432-05 | — | 1 July 2020 |
| 25 vial, glass in 1 box / 2 mL in 1 vial, glass | 68083-432-25 | — | 1 July 2020 |
| 25 vial in 1 carton / 2 mL in 1 vial | 42571-436-87 | — | 1 March 2026 |
| 25 vial in 1 tray / 2 mL in 1 vial | 63323-280-02 | — | 12 July 2000 |
| 25 vial in 1 tray / 2 mL in 1 vial | 63323-280-16 | — | 12 July 2000 |
| 25 vial, single-dose in 1 tray / 2 mL in 1 vial, single-dose | 0409-6102-02 | — | 28 February 2005 |
| 25 vial, single-dose in 1 tray / 2 mL in 1 vial, single-dose | 0409-6102-25 | — | 19 November 2013 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 71288-203-03 | — | 27 January 2022 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 71288-203-92 | — | 27 January 2022 |
| 25 vial in 1 carton / 2 mL in 1 vial | 25021-311-02 | — | 15 March 2021 |
| 25 vial in 1 carton / 2 mL in 1 vial | 25021-320-02 | — | 15 July 2025 |
| 25 vial, glass in 1 carton / 2 mL in 1 vial, glass | 70121-1163-5 | — | 25 July 2016 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 0143-9155-25 | — | 31 May 2024 |
| 25 vial in 1 tray / 2 mL in 1 vial | 81565-201-02 | — | 1 February 2022 |
| 5 vial in 1 bag / 2 mL in 1 vial | 55154-2364-5 | — | 13 July 2010 |
| 5 vial in 1 bag / 2 mL in 1 vial | 55154-9581-5 | — | 12 July 2000 |
| 2 mL in 1 vial, single-use | 51662-1227-1 | — | 14 September 2018 |
| 2 mL in 1 vial | 51662-1572-1 | — | 28 June 2021 |
| 25 pouch in 1 case / 1 vial in 1 pouch / 2 mL in 1 vial | 51662-1572-3 | — | 12 June 2022 |
| 25 vial, single-dose in 1 carton / 2 mL in 1 vial, single-dose | 83634-302-02 | — | 15 March 2024 |
| 1 vial in 1 bag / 2 mL in 1 vial | 0404-9864-02 | — | 10 January 2022 |
| 1 vial in 1 bag / 2 mL in 1 vial | 71872-7236-1 | — | 15 December 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Furosemide 20 mg/2 mL injection.
Other strengths and forms of Furosemide
Clinical summary
Furosemide is a loop diuretic indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. MedsAcross supplies Furosemide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about FurosemideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lasix prescribing information (Validus Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Bopediat: European public assessment report (EPAR) · European Medicines Agency
Need Furosemide 20 mg/2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.